Concepedia

Anna Norrby‐Teglund

AN

Statistics

Publications

115

Citations

12.5K

H-Index

55

Active since

1994

Affiliations

Karolinska Institutet(Current)

Karolinska University Hospital

Lund University

Haukeland University Hospital

Rigshospitalet

Anna Norrby‐Teglund is an author at Karolinska Institutet specializing in life sciences, infectious diseases, and immunology.

ORCID

Publications per year

1994–2025

115

Publications

115

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros et al. · Cell · 2020 · 2K citations · Full text

, , +15

Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial

Jessica Darenberg, Nahla Ihendyane, Jan Sjölin et al. · Clinical Infectious Diseases · 2003 · 573 citations · Full text

, , +14

Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study

Rupert Kaul, Allison McGeer, Anna Norrby‐Teglund et al. · Clinical Infectious Diseases · 1999 · 548 citations · Full text

, , +14

Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation

Maren von Köckritz‐Blickwede, Oliver Goldmann, Pontus Thulin et al. · Blood · 2008 · 539 citations

, , +13

Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock*

Jonas Sundén‐Cullberg, Anna Norrby‐Teglund, Ari Rouhiainen et al. · Critical Care Medicine · 2005 · 427 citations

, , +16

1–5 of 115